Interventional Cardiology Devices | Market Insights | US | 2020
The US IC device market will continue to be negatively affected by policies that contribute to declining ASPs, such as Medicare coverage for low-complexity catheterization procedures performed in nonhospital facilities, reimbursement equalization between different sites of service, and cost-containment measures. However, these effects will be mitigated by rising procedure volumes, particularly for complex CAD, as well as the emergence of specialized premium-priced technologies to treat these complex cases.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in the US, with market projections across a 10-year period.
